Defining a hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

Primary therapy for Hodgkin lymphoma (HL) is curative in ˜ 85% of patients [1]. Randomized phase III and single arm phase II trials have established high dose chemotherapy and autologous hematopoie...